“Bioinformatics is essential for the use of personalized medicine against cancer in a systematic way” explained Valencia who also stressed that while the molecular biology “is instrumented and robotized and generate large amounts of data: genomic expression, proteomic … biocomputing not keeping pace “and stressed that “we need to invest more in this area”.

About Dr. Alfonso Valencia

Dr. Alfonso Valencia

is a biologist with formal training in population genetics and biophysics which he received from the Universidad Complutense de Madrid. He was awarded his PhD at the Universidad Autónoma de Madrid. In 1994 he set up the Protein Design group at the National Center of Biotechnology, CSIC. Member of the European Molecular Biology Organization (EMBO), he is founder and vice-president of the International Society for Computational Biology.